RecallDepth
Class I Terminated

Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11

This recall has been terminated (originally issued May 6, 2020).

Company
B. Braun Medical Inc
Recall Initiated
April 18, 2020
Posted
May 6, 2020
Recall Number
D-1257-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
22,488 Duplex containers
Firm Location
Irvine, CA, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.

Distribution

Product was distributed nationwide within the United States.

Lot / Code Info

Lot #: H8J812, Exp. Date 31 JUL 2020

More recalls by B. Braun Medical Inc

View all recalls by this company →

Other recent Class I Drug recalls